Advisor Group’s Immune Design Corp. IMDZ Stock Holding History

Advisor Group’s Portfolio IMDZ Stock Details IMDZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-500	Closed	-$1K	–	5520
2018 Q4	$1K	Hold	500	–	–	﹤0.01%	5075
2018 Q3	$2K	Buy	+500	New	+$1.88K	﹤0.01%	4922

Other funds holding IMDZ

Peter Svennilson $1.23B AUM 301.34% 1-Year Est. Return

AAM

Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

TAL

TIG Advisors LLC New York $2.16B AUM 72.99% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Gabelli Funds Rye, New York $14.8B AUM 32.24% 1-Year Est. Return

SAM

Sandell Asset Management New York $179M AUM 65.55% 1-Year Est. Return

BCM

Beryl Capital Management Redondo Beach, California $110M AUM 317.92% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Man Group London, United Kingdom $55.1B AUM 24.23% 1-Year Est. Return

Advisor Group's IMDZ Position: Q1 2019 in Review

Advisor Group sold out of Immune Design Corp. (IMDZ) in Q1 2019, closing a stake of 500 shares — an estimated $1K sold.

Advisor Group first reported a position in IMDZ in Q3 2018 and held it in 2 quarters. The position peaked at $2K in Q3 2018. 68 funds tracked by Wall St. Rank hold IMDZ as of Q1 2019.

Advisor Group reported no remaining Immune Design Corp. position as of Q1 2019 after selling out during the quarter.
Advisor Group sold 500 Immune Design Corp. shares in Q1 2019, an estimated $1K.
Advisor Group first reported a position in Immune Design Corp. in Q3 2018 and held it in 2 quarters.
Advisor Group's Immune Design Corp. position peaked at $2K in Q3 2018.
68 funds tracked by Wall St. Rank held Immune Design Corp. as of Q1 2019.

Based on Advisor Group's 13F filing for Q1 2019, filed 9 May 2019.